pantoprazole has been researched along with Peritonitis in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the most widely accepted treatment for peptic ulcer perforation is surgery, non-operative treatment can be an option in selected patients." | 1.51 | Non-operative management of perforated peptic ulcer: A single-center experience. ( Dinçer, M; Karabulut, K; Liman, RK; Usta, S, 2019) |
| "In 84 consecutive cirrhotic patients, bacterial infection risk was prospectively assessed and related to PPI use." | 1.38 | Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. ( de Rooij, FW; Huisman, EJ; Renooij, W; Siersema, PD; van Erpecum, KJ; van Hoek, B; van Vlerken, LG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karabulut, K | 1 |
| Dinçer, M | 1 |
| Liman, RK | 1 |
| Usta, S | 1 |
| van Vlerken, LG | 1 |
| Huisman, EJ | 1 |
| van Hoek, B | 1 |
| Renooij, W | 1 |
| de Rooij, FW | 1 |
| Siersema, PD | 1 |
| van Erpecum, KJ | 1 |
2 other studies available for pantoprazole and Peritonitis
| Article | Year |
|---|---|
Non-operative management of perforated peptic ulcer: A single-center experience.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Fluid Therapy; Humans; Length of Stay; Pantoprazole; Pepti | 2019 |
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Animals; Bacteria; Bacterial Infections; Cohor | 2012 |